Enlaces de interes
Medicines and Health Technologies
The Medicines and Health Technologies Unit (HSS/MT) provides technical cooperation to Member States in developing policies, plans and strategies to ensure access to medicines, vaccines and other health technologies; to strengthen governance capacity and regulation, and the support of national systems to facilitate access to vaccines and medicines through regional procurement mechanisms, collaborative networks, and regional platform such as the Regional Platform on Access and Innovation for Health Technologies.
PLISA. Health Information Platform for the Americas
This PAHO database presents core health indicators, health analysis, mortality and other health topics of interest.
PAHO/WHO Institutional Repository for Information Sharing
This platform is a result of the organizational strategy to preserve and provide access to its wealth of information in health sciences, and the history of technical cooperation between PAHO/WHO and the Member States in the Region of the Americas.
PAHO Strategic Fund
The Strategic Fund of the Pan American Health Organization (PAHO) is a mechanism for the pooled procurement of essential medicines and strategic health supplies that save lives. As such, the Fund constitutes an important element of PAHO’s strategy to further progress towards Universal Health.
THE CARIBBEAN REGULATORY SYSTEM (CRS)
The Caribbean Regulatory System (CRS) is an initiative of the Caribbean Community and Common Market (CARICOM) and is managed as a regulatory unit within CARICOM’s regional public health body, the Caribbean Public Health Agency (CARPHA). It is supported by a number of partners, including the Pan American Health Organization/World Health Organization (PAHO/WHO), PAHO designated National Regulatory Authorities of Regional Reference (NRA/RR) (Argentina, Brazil, Canada, Chile, Colombia, Cuba, Mexico, United States), and the Bill and Melinda Gates Foundation (BMGF).
Red de Evaluación de Tecnologías en Salud de las Américas – RedETSA
Essential medicines and health products
National governments are responsible for establishing strong national medicines regulatory authorities (MRAs) with clear mission, solid legal basis, realistic objectives, appropriate organizational structure, adequate number of qualified staff, sustainable financing, access to up-to-date evidence based technical literature.
WHO Model Lists of Essential Medicines
The WHO Model Lists of Essential Medicines has been updated every two years since 1977. The current versions are the 20th WHO Essential Medicines List (EML) and the 6thWHO Essential Medicines List for Children (EMLc) updated in March 2017.
The Drug Regulatory Status Database (HIV/AIDS)
The DRS is a database of the registration status of antiretroviral drugs in low, lower middle and upper middle income countries. The DRS focuses only on ARVs which have been approved through the WHO prequalification programme or have been approved through a stringent regulatory process.
WHO Medical devices
Regulation is primarily concerned with enabling patient access to high quality, safe and effective medical devices, and avoiding access to products that are unsafe. When appropriately implemented, regulation ensures public health benefit and the safety of patients, health care workers and the community.
Blood safety and availability
Access information on blood policy organization and blood supply worldwide.
Global Health Observatory (GHO) data
The Global Health Observatory theme pages provide data and analyses on global health priorities. Each theme page provides information on global situation and trends highlights, using core indicators, database views, major publications and links to relevant web pages on the theme.